MPG.eBooks - Description: CADTH Canadian Drug Expert Committee recommendation: Cysteamine delayed-release (Procysbi -- Horizon Pharma Ireland Ltd.)

Read Now

The Canadian Drug Expert Committee (CDEC) recommends that delayed-release cysteamine be reimbursed for treatment of nephropathic cystinosis

Bibliographic Details
Corporate Authors:	CADTH Canadian Drug Expert Committee, Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2018, January 2018
Edition:	Version 1.0
Series:	CADTH common drug review
Subjects:	Insurance, Health, Reimbursement Canada Cysteamine / Therapeutic Use Cost-benefit Analysis Cystinosis / Drug Therapy Cystine Depleting Agents / Economics
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK533470
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa

Description
Summary:	The Canadian Drug Expert Committee (CDEC) recommends that delayed-release cysteamine be reimbursed for treatment of nephropathic cystinosis
Item Description:	"Final."
Physical Description:	1 PDF file (7 pages)